Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
McKinsey
Colorcon
Dow
Merck
US Army
Medtronic
Cipla

Generated: May 26, 2018

DrugPatentWatch Database Preview

ORVATEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Orvaten, and what generic alternatives are available?

Orvaten is a drug marketed by Upsher-smith Labs and is included in one NDA.

The generic ingredient in ORVATEN is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.
Drug patent expirations by year for ORVATEN
Pharmacology for ORVATEN
Medical Subject Heading (MeSH) Categories for ORVATEN
Synonyms for ORVATEN
(+-)-2-amino-1-(2,5-dimethoxyphenyl)ethanol
(+/-)-2-Amino-1-(2, 5 dimethoxyphenyl) ethanol
(+/-)-2-amino-1-(2,5-dimethoxyphenyl)ethanol
1-(2',5'-dimethoxyphenyl)-2-aminoethanol
1-(2',5'-Dimethoxyphenyl)aminoethanol
2-Amino-(2,5-dimethoxyphenyl)ethanol
2-Amino-1-(2,5-dimethoxy-phenyl)-ethanol
2-amino-1-(2,5-dimethoxyphenyl)ethan-1-ol
2-amino-1-(2,5-dimethoxyphenyl)ethanol
2-Amino-1-(2,5-dimethoxyphenyl)ethanol, AldrichCPR
2-amino-1-(2',5'-dimethoxyphenyl) ethanol
2-amino-1-(2',5'-dimethoxyphenyl)ethanol
2,5-Dimethoxy-beta-hydroxyphenethylamine
3600-87-1
52047-77-5
600A871
60407-53-6 (hydrochloride)
AB01002492-01
AC1L29I0
AC1Q4871
AC1Q4872
AK-87640
AKOS000123871
AKOS016842856
alpha-(Aminomethyl)-2,5-dimethoxybenzenemethanol
ANW-57405
BDBM50118702
Benzenemethanol, a-(aminomethyl)-2,5-dimethoxy-
Benzyl alcohol, alpha-(aminomethyl)-2,5-dimethoxy-
C21521
CHEBI:73248
CHEMBL1076
CTK4H5735
DB-027711
de-glymidodrine
Deglymidodrine
DESGLYMIDODRINE
EN300-36742
FT-0674660
KB-19462
MCULE-6688431628
MFCD03701227
Midodrine Related Compound A (Desglymidodrine)
MolPort-001-793-604
NE21743
OR149381
rac-2-amino-1-(2,5-dimethoxyphenyl)ethanol
SCHEMBL476432
ST 1059
ST-1059
ST50407701
TC-146150
VFRCNXKYZVQYLX-UHFFFAOYSA-N
Z380844680

US Patents and Regulatory Information for ORVATEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs ORVATEN midodrine hydrochloride TABLET;ORAL 076725-001 Nov 3, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs ORVATEN midodrine hydrochloride TABLET;ORAL 076725-002 Nov 3, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs ORVATEN midodrine hydrochloride TABLET;ORAL 076725-003 Nov 3, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
US Department of Justice
Accenture
Cantor Fitzgerald
Mallinckrodt
Queensland Health
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.